CVS Health Corporation announced a strong third-quarter performance with revenues of $81.2 billion and a raised adjusted EPS guidance range of $8.55 to $8.65, reflecting robust market confidence. The company also declared a quarterly dividend of $0.55 per share, maintaining a 2.25% yield, supported by bullish sentiment from 67 hedge funds. In contrast, Meta Platforms, Inc. struggled with a 16% decline during the same period, underscoring CVS's favorable position in a volatile market.
Click a month on the chart to update the report below.
